IDX21459

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDX21459, covering 2016-01-26 to 2016-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects [Phase 1]